|
|
|
Volumn 50, Issue 1290, 2008, Pages 53-
|
|
Varenicline (Chantix) warnings: risk versus benefit.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BENZAZEPINE DERIVATIVE;
NICOTINIC AGENT;
QUINOXALINE DERIVATIVE;
VARENICLINE;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
HUMAN;
MENTAL DISEASE;
METHODOLOGY;
PARTIAL AGONISM;
PSYCHOLOGICAL ASPECT;
RISK ASSESSMENT;
RISK FACTOR;
SMOKING CESSATION;
TOBACCO DEPENDENCE;
TREATMENT OUTCOME;
BENZAZEPINES;
DRUG PARTIAL AGONISM;
HUMANS;
MENTAL DISORDERS;
NICOTINIC AGONISTS;
QUINOXALINES;
RISK ASSESSMENT;
RISK FACTORS;
SMOKING CESSATION;
TOBACCO USE DISORDER;
TREATMENT OUTCOME;
|
|
EID: 49249125131
PISSN: None
EISSN: 15232859
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|